Join to view full profile
1349 S Rochester RdSte 150Rochester, MI 48307
Phone+1 248-844-2700
Fax+1 248-844-0991
Dr. Beydoun is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rafic Beydoun is a pathology specialist based in Rochester, MI, with subspecialties in gastrointestinal and hepatobiliary pathology, anatomic pathology, clinical pathology, and surgical pathology. He graduated from Damascus University Faculty of Medicine in 1980 and has experience in oral pathology. Dr. Beydoun has contributed to several publications primarily focusing on pancreatic cancer research, including studies on Ran GTPase, Janus kinase 1, and the anticancer efficacy of KRASG12C inhibitors. His work has been published in reputable journals such as Cancer Letters, Cell Reports, Cureus, and Molecular Cancer Therapeutics.
Education & Training
Damascus University Faculty of MedicineClass of 1980
Certifications & Licensure
FL State Medical License 1991 - 2028
MI State Medical License 2005 - 2028
TX State Medical License 2022 - 2028
PA State Medical License 1992 - 2026
American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- XPO1 inhibition enhances the efficacy and durability of RAS-targeted therapy in preclinical models of KRASG12D mutant pancreatic ductal adenocarcinoma.Husain Yar Khan, Mohammed Najeeb Al Hallak, Amro Aboukameel, Sahar F Bannoura, Md Hafiz Uddin
Cancer Letters. 2026-11-01 - Genomic and Transcriptomic Landscapes of MEN1-Wild-Type Low-Grade Metastatic Pancreatic NETs Uncover Key Oncogenic Drivers and Targetable Pathways.Md Hafiz Uddin, Zaid Mahdi, Irfana Muqbil, Brendon R Herring, Bart Rose
International Journal of Biological Sciences. 2026-01-01 - Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma.Husain Yar Khan, Mohammed Najeeb Al Hallak, Amro Aboukameel, Sahar F Bannoura, Md Hafiz Uddin
Biorxiv. 2025-11-25
Journal Articles
- Paratesticular myxoid liposarcoma: A case Report of Unusual Age of Presentationk. Al-Obaidy, E. Abdulfatah, F. Lonardo and Rafic Beydoun, Journal of Molecular Biomatkers & Diagnosis, 4/25/2017
- Myoepithelial carcinoma of the posterior mediastinum: An uncommon site for a rare tumorEman Abdulfatah, Rafic Beydoun, M.D., Sudeshna Bandyopadhyay, M.D. Department of Pathology, Wayne State University, 540 East Canfield Avenue, Detroit, Michigan 48201, Human pathology, 3/9/2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: